The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 14, 2017
Filed:
Jan. 20, 2012
Applicants:
Isabel Kalofonos, Cambridge, MA (US);
Judy Caron, Cambridge, MA (US);
William Martin-doyle, Cambridge, MA (US);
Inventors:
Isabel Kalofonos, Cambridge, MA (US);
Judy Caron, Cambridge, MA (US);
William Martin-Doyle, Cambridge, MA (US);
Assignee:
Bionevia Pharmaceuticals Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/425 (2006.01); A01N 43/78 (2006.01); A61K 31/426 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 47/26 (2006.01); A61K 9/16 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/426 (2013.01); A61K 9/1652 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 9/282 (2013.01); A61K 9/284 (2013.01); A61K 9/2886 (2013.01); A61K 47/26 (2013.01); A61K 9/0019 (2013.01); A61K 9/1623 (2013.01);
Abstract
Modified release pharmaceutical compositions of epalrestat are provided. Methods of manufacturing the tablets and treating various diseases and conditions, including diabetes and diabetic complications, by administering the modified release compositions to patients in need thereof are also provided.